Our reviews

Our Reviews

Full list

By Subtopic

New - Updated

Select stage:(Stage filter not available for Subtopic view)

All

Protocols

Reviews

Full list:

5-alpha-reductase inhibitors for lower urinary tract symptoms secondary to benign prostatic obstruction

5-alpha-reductase inhibitors for prostate cancer prevention

Serenoa repens for benign prostatic hyperplasia

Abiraterone acetate in combination with androgen deprivation therapy compared to androgen deprivation therapy only for metastatic hormone-sensitive prostate cancer

Adjuvant chemotherapy for invasive bladder cancer (individual patient data)

Adjuvant radiotherapy following radical prostatectomy for prostate cancer

Allopurinol for chronic prostatitis

Alpha-blockers after shock wave lithotripsy for renal or ureteral stones in adults

Alpha-blockers as medical expulsive therapy for ureteral stones

Alvimopan for recovery of bowel function after radical cystectomy

Antibiotic prophylaxis for transrectal prostate biopsy

Anticholinergics combined with alpha-blockers for treating lower urinary tract symptoms related to benign prostatic obstruction

Antimicrobial agents for preventing urinary tract infections in adults undergoing cystoscopy

Antimicrobial therapy for chronic bacterial prostatitis

Apomorphine for the treatment of erectile dysfunction

Aquablation of the prostate for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia

Beta-sitosterols for benign prostatic hyperplasia

Bipolar versus monopolar transurethral resection of the prostate for lower urinary tract symptoms secondary to benign prostatic obstruction

Bisphosphonates for advanced prostate cancer

Bisphosphonates or RANK-ligand-inhibitors for men with prostate cancer and bone metastases: a network meta-analysis

Blue versus white light for transurethral resection of non-muscle invasive bladder cancer

Chemoprevention agents for prostate cancer

Chemotherapy for hormone-refractory prostate cancer

Circumcision devices versus standard surgical techniques in adolescent and adult male circumcisions

Convective radiofrequency water vapour thermal therapy for lower urinary tract symptoms in men with benign prostatic hyperplasia

Cytoreductive nephrectomy in metastatic renal cell carcinoma

Degarelix for treating advanced hormone-sensitive prostate cancer

Desmopressin for treating nocturia in men

Dose-escalated radiotherapy for clinically localised and locally advanced prostate cancer

Early versus deferred standard androgen suppression therapy for advanced hormone-sensitive prostate cancer

En-bloc resection versus conventional transurethral resection for patients with non-muscle-invasive bladder cancer

Extended versus standard lymph node dissection for urothelial carcinoma of the bladder in patients undergoing radical cystectomy

Extracorporeal shockwave therapy for the treatment of erectile dysfunction

Finasteride for benign prostatic hyperplasia

First-line therapy for adults with advanced renal cell carcinoma: a systematic review and network meta-analysis

Gemcitabine for unresectable, locally advanced or metastatic bladder cancer

Ginseng for erectile dysfunction

Holmium laser enucleation of the prostate for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia

Hypofractionation for clinically localized prostate cancer

Image-guided percutaneous renal core biopsy of small renal masses to diagnose renal cancer

Immunotherapy for advanced or metastatic urothelial carcinoma

Immunotherapy for metastatic renal cell carcinoma

Intermittent versus continuous androgen suppression for prostatic cancer

Interventions for chronic abacterial prostatitis

Interventions for treating chronic prostatitis/chronic pelvic pain syndrome

Intravesical Bacillus Calmette-Guérin in Ta and T1 bladder cancer

Intravesical Bacillus Calmette-Guérin versus epirubicin for Ta and T1 bladder cancer

Intravesical Bacillus Calmette-Guérin versus mitomycin C for Ta and T1 bladder cancer

Intravesical Bacillus Calmette-Guérin with interferon-alpha versus intravesical Bacillus Calmette-Guérin for treating non-muscle-invasive bladder cancer

Intravesical electromotive drug administration for non-muscle invasive bladder cancer

Intravesical gemcitabine for non-muscle invasive bladder cancer

Intravesical therapy for non-muscle invasive bladder cancer: a network meta-analysis

Laparoscopic and robotic-assisted versus open radical prostatectomy for the treatment of localised prostate cancer

Laser prostatectomy for benign prostatic obstruction

Low-dose rate brachytherapy for men with localized prostate cancer

Lycopene for the prevention of prostate cancer

Maximal androgen blockade for advanced prostate cancer

Medical and dietary interventions for preventing recurrent urinary stones in children

Medical and surgical interventions for the treatment of urinary stones in children

Minimally invasive treatments for lower urinary tract symptoms in men with benign prostatic hyperplasia: a network meta-analysis

Naftopidil for the treatment of lower urinary tract symptoms compatible with benign prostatic hyperplasia

Narrow band imaging versus white light cystoscopy alone for transurethral resection of non-muscle invasive bladder cancer

Neo-adjuvant and adjuvant hormone therapy for localised and locally advanced prostate cancer

Neo-adjuvant chemotherapy for invasive bladder cancer

Non-pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome

Non-steroidal antiandrogen monotherapy compared with luteinising hormone–releasing hormone agonists or surgical castration monotherapy for advanced prostate cancer

Non-surgical therapies for Peyronie's disease

Palliation of metastatic bone pain: single fraction versus multifraction radiotherapy

Partial nephrectomy versus radical nephrectomy for clinical localised renal masses

Pembrolizumab monotherapy versus chemotherapy for treatment of advanced urothelial carcinoma with disease progression during or following platinum-containing chemotherapy. A Cochrane Rapid Review

Penile rehabilitation for postprostatectomy erectile dysfunction

Percutaneous nephrolithotomy versus retrograde intrarenal surgery for treatment of renal stones in adults

Perioperative nutrition for the treatment of bladder cancer by radical cystectomy

Perioperative systemic chemo-immunotherapy for upper urinary tract urothelial carcinoma

Pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome

Phosphodiesterase inhibitors for lower urinary tract symptoms consistent with benign prostatic hyperplasia

Physical activity for lower urinary tract symptoms secondary to benign prostatic obstruction

Posterior musculofascial reconstruction in robotic-assisted laparoscopic prostatectomy for the treatment of clinically localized prostate cancer

Pregabalin for chronic prostatitis

Primary cryotherapy for localised or locally advanced prostate cancer

Prostate MRI, with or without MRI-targeted biopsy, and systematic biopsy for detecting prostate cancer

Prostatic arterial embolization for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia

Prostatic urethral lift for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia

Psychosocial interventions for erectile dysfunction

Psychosocial interventions for men with prostate cancer

Psychosocial interventions for premature ejaculation

Pygeum africanum for benign prostatic hyperplasia

Radical prostatectomy versus deferred treatment for localised prostate cancer

Retzius-sparing versus standard robotic-assisted laparoscopic prostatectomy for the treatment of clinically localized prostate cancer.

Robotic versus open radical cystectomy for bladder cancer in adults

Screening for prostate cancer

Screening for testicular cancer

Selective serotonin re-uptake inhibitors for premature ejaculation in adult men

Silodosin for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia

Single-dose intravesical chemotherapy after nephroureterectomy for upper tract urothelial carcinoma

Surgery versus non-surgical management for unilateral ureteric-pelvic junction obstruction in newborns and infants less than two years of age

Surgery versus radiotherapy for muscle invasive bladder cancer

Surgical management for upper urinary tract transitional cell carcinoma

Targeted therapy for advanced renal cell carcinoma

Targeted therapy for metastatic renal cell carcinoma

Taxane-based chemohormonal therapy for metastatic hormone-sensitive prostate cancer

Transurethral microwave thermotherapy for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia

Tubeless versus tubed percutaneous nephrolithotomy for treating kidney stones

Ureteral stent versus no ureteral stent for ureteroscopy in the management of renal and ureteral calculi

Water for preventing urinary stones

By subtopic:

Benign Prostatic Hyperplasia/Obstruction (Hypertrophy, Prostatic Hyperplasia) (26)

Screening for Benign Prostatic Hyperplasia (0)

Urodynamics (0)

Treatment of Benign Prostatic Hyperplasia (25)

Dietary/Lifestyle (0)

Surgical (2)

Prostatectomy (0)

Transurethral resection of the prostate (TURP) (2)

Aquablation of the prostate for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia

Bipolar versus monopolar transurethral resection of the prostate for lower urinary tract symptoms secondary to benign prostatic obstruction

Transvesical prostatectomy (TVP) (0)

Pharmacologic/Medical Therapies (14)

Alpha-blockers/Alpha-1 adrenoceptors/Alpha antagonists/5-alpha reductase inhibitors (6)

Alfuzosin (1)

Anticholinergics combined with alpha-blockers for treating lower urinary tract symptoms related to benign prostatic obstruction

Doxazosin (1)

Anticholinergics combined with alpha-blockers for treating lower urinary tract symptoms related to benign prostatic obstruction

Finasteride (0)

Naftopidil (2)

Anticholinergics combined with alpha-blockers for treating lower urinary tract symptoms related to benign prostatic obstruction

Naftopidil for the treatment of lower urinary tract symptoms compatible with benign prostatic hyperplasia

Prazosin (0)

Tamsulosin (1)

Anticholinergics combined with alpha-blockers for treating lower urinary tract symptoms related to benign prostatic obstruction

Terazosin (1)

Anticholinergics combined with alpha-blockers for treating lower urinary tract symptoms related to benign prostatic obstruction

Androgen Suppression (3)

Gonadotropin-releasing hormone agonists (0)

Antiandrogens (0)

5 Alpha-reductase inhibitors (3)

5-alpha-reductase inhibitors for lower urinary tract symptoms secondary to benign prostatic obstruction (protocol stage)

Finasteride for benign prostatic hyperplasia

Silodosin for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia

Combined androgen suppression and alpha-blockade (0)

Anticholinergics (1)

Anticholinergics combined with alpha-blockers for treating lower urinary tract symptoms related to benign prostatic obstruction

Desmopressin (1)

Desmopressin for treating nocturia in men

Indoles (0)

Meparticin (0)

Phytotherapies/Plant extracts (3)

Pygeum africanum for benign prostatic hyperplasia

Beta-sitosterols for benign prostatic hyperplasia

Serenoa repens for benign prostatic hyperplasia

Minimally Invasive Procedures (9)

Acupuncture (0)

Balloon dilation (0)

Laser prostatectomy (4)

Enucleation (1)

Holmium laser enucleation of the prostate for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia (protocol stage)

Visual laser ablation of the prostate (VLAP) (1)

Laser prostatectomy for benign prostatic obstruction

Endoscopic laser ablation of the prostate (ELAP) (1)

Laser prostatectomy for benign prostatic obstruction

Hybrid lasers (1)

Laser prostatectomy for benign prostatic obstruction

Transuretal ultrasound-guided (TULIP) (0)

Microwave/Thermo Therapies (1)

Transurethral microwave therapy (TUMT) (1)

Transurethral microwave thermotherapy for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia

Transrectal hyperthermia (TRH) (0)

Transurethral electroresection (TUEP) (0)

Miscellaneous (3)

Convective radiofrequency water vapour thermal therapy for lower urinary tract symptoms in men with benign prostatic hyperplasia

Minimally invasive treatments for lower urinary tract symptoms in men with benign prostatic hyperplasia: a network meta-analysis (protocol stage)

Prostatic arterial embolization for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia

Transrectal High-Intensity Focused Ultrasound Therapy (0)

Transrectal Needle Ablation of the Prostate (0)

Mechanical (1)

Devices/stents (1)

Prostatic urethral lift for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia

Catheters (0)

Artificial sphincters (0)

Rehabilitation/Management of Benign Prostatic Hyperplasia (1)

Physical activity for lower urinary tract symptoms secondary to benign prostatic obstruction

Diagnostic test accuracy (1)

Prostate MRI, with or without MRI-targeted biopsy, and systematic biopsy for detecting prostate cancer

Miscellaneous (13)

Alpha-blockers after shock wave lithotripsy for renal or ureteral stones in adults

Alpha-blockers as medical expulsive therapy for ureteral stones

Antimicrobial agents for preventing urinary tract infections in adults undergoing cystoscopy

Circumcision devices versus standard surgical techniques in adolescent and adult male circumcisions

Water for preventing urinary stones

Medical and surgical interventions for the treatment of urinary stones in children

Medical and dietary interventions for preventing recurrent urinary stones in children

Non-surgical therapies for Peyronie's disease (protocol stage)

Percutaneous nephrolithotomy versus retrograde intrarenal surgery for treatment of renal stones in adults (protocol stage)

Phosphodiesterase inhibitors for lower urinary tract symptoms consistent with benign prostatic hyperplasia

Ureteral stent versus no ureteral stent for ureteroscopy in the management of renal and ureteral calculi

Surgery versus non-surgical management for unilateral ureteric-pelvic junction obstruction in newborns and infants less than two years of age

Tubeless versus tubed percutaneous nephrolithotomy for treating kidney stones (protocol stage)

Premature ejaculation (PE) (2)

Psychosocial interventions for premature ejaculation

Selective serotonin re-uptake inhibitors for premature ejaculation in adult men

Prostatitis/Prostatitis Syndromes and Prostatodynia (10)

Treatment of Acute Bacterial Prostatitis (0)

Antibiotics (0)

Short Course versus Long Course (0)

Suppressive (0)

Dietary and Lifestyle (0)

Treatment of Chronic Bacterial Prostatitis (2)

Alternative therapies (1)

Pregabalin for chronic prostatitis

Antibiotics (0)

Short Course versus Long Course (0)

Suppressive (1)

Antimicrobial therapy for chronic bacterial prostatitis

Dietary and Lifestyle (0)

Treatment of Acute/Chronic Abacterial (Nonbacterial) Prostatitis/Chronic Pelvic Pain Syndrome (8)

5-alpha reductase inhibitors (0)

Antibiotics (4)

Non-pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome

Pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome

Interventions for treating chronic prostatitis/chronic pelvic pain syndrome (protocol stage)

Interventions for chronic abacterial prostatitis

Diet, Exercise and Lifestyle (0)

Allopurinol (2)

Allopurinol for chronic prostatitis

Interventions for chronic abacterial prostatitis

Alpha-blockers (1)

Interventions for chronic abacterial prostatitis

Microwave Therapy (1)

Interventions for chronic abacterial prostatitis

Pain Management (0)

Treatment of Prostatodynia (0)

Diet (0)

Anti-inflammatory Drugs (0)

Muscle Relaxants (0)

Sitz-baths (0)

Prostate Cancer (Malignancy, Neoplasm) (27)

Cryotherapy (1)

Primary cryotherapy for localised or locally advanced prostate cancer

Immunotherapy (0)

Laparoscopic prostatectomy (1)

Retzius-sparing versus standard robotic-assisted laparoscopic prostatectomy for the treatment of clinically localized prostate cancer.

Lymph Node Dissection (0)

Prevention of Prostate Cancer (4)

Diet (1)

Fat modified (0)

Antioxidants (1)

Lycopene for the prevention of prostate cancer

Pharmacologic/Medical (3)

5-alpha-reductase inhibitors (1)

5-alpha-reductase inhibitors for prostate cancer prevention

Finasteride (0)

Hormones (1)

Taxane-based chemohormonal therapy for metastatic hormone-sensitive prostate cancer

Other (1)

Chemoprevention agents for prostate cancer (protocol stage)

Surgery (0)

Prognostic markers (0)

Radical prostatectomy (RP) (3)

Laparoscopic and robotic-assisted versus open radical prostatectomy for the treatment of localised prostate cancer

Radical prostatectomy versus deferred treatment for localised prostate cancer

Posterior musculofascial reconstruction in robotic-assisted laparoscopic prostatectomy for the treatment of clinically localized prostate cancer

Risk Stratification Tools (0)

Screening for Prostate Cancer (1)

Screening for prostate cancer

Rehabilitation/Management of Prostate Cancer (17)

Abiraterone acetate in combination with androgen deprivation therapy compared to androgen deprivation therapy only for metastatic hormone-sensitive prostate cancer

Non-steroidal antiandrogen monotherapy compared with luteinising hormone–releasing hormone agonists or surgical castration monotherapy for advanced prostate cancer

Antibiotic prophylaxis for transrectal prostate biopsy

Bisphosphonates for advanced prostate cancer

Bisphosphonates or RANK-ligand-inhibitors for men with prostate cancer and bone metastases: a network meta-analysis

Chemotherapy for hormone-refractory prostate cancer

Degarelix for treating advanced hormone-sensitive prostate cancer

Dose-escalated radiotherapy for clinically localised and locally advanced prostate cancer (protocol stage)

Early versus deferred standard androgen suppression therapy for advanced hormone-sensitive prostate cancer

Palliation of metastatic bone pain: single fraction versus multifraction radiotherapy

Low-dose rate brachytherapy for men with localized prostate cancer

Maximal androgen blockade for advanced prostate cancer

Neo-adjuvant and adjuvant hormone therapy for localised and locally advanced prostate cancer

Psychosocial interventions for men with prostate cancer

Adjuvant radiotherapy following radical prostatectomy for prostate cancer

Intermittent versus continuous androgen suppression for prostatic cancer

Hypofractionation for clinically localized prostate cancer

Urothelial carcinoma (Malignancy, Neoplasia): [Superficial, muscle-invasive, metastatic} (25)

Diet/nutrition (1)

Perioperative nutrition for the treatment of bladder cancer by radical cystectomy

Treatment of Superficial Bladder Cancer (13)

Bacillus Calmette Guerin (BCG) (5)

Intravesical Bacillus Calmette-Guérin versus mitomycin C for Ta and T1 bladder cancer

Intravesical Bacillus Calmette-Guérin versus epirubicin for Ta and T1 bladder cancer

Intravesical therapy for non-muscle invasive bladder cancer: a network meta-analysis (protocol stage)

Intravesical Bacillus Calmette-Guérin with interferon-alpha versus intravesical Bacillus Calmette-Guérin for treating non-muscle-invasive bladder cancer

Intravesical Bacillus Calmette-Guérin in Ta and T1 bladder cancer

Chemotherapy (2)

Intravesical gemcitabine for non-muscle invasive bladder cancer

Intravesical therapy for non-muscle invasive bladder cancer: a network meta-analysis (protocol stage)

Intravesical electromotive drug administration for non-muscle invasive bladder cancer

Intravesical therapy for non-muscle invasive bladder cancer: a network meta-analysis (protocol stage)

Photodynamic Therapy (Hematoporphyrin Derivative (HpD) (0)

Surgery (3)

Blue versus white light for transurethral resection of non-muscle invasive bladder cancer (protocol stage)

En-bloc resection versus conventional transurethral resection for patients with non-muscle-invasive bladder cancer (protocol stage)

Narrow band imaging versus white light cystoscopy alone for transurethral resection of non-muscle invasive bladder cancer (protocol stage)

Thiotepa (1)

Intravesical therapy for non-muscle invasive bladder cancer: a network meta-analysis (protocol stage)

Treatment of Muscle-invasive Bladder Cancer (7)

Adjuvant therapy (1)

Adjuvant chemotherapy for invasive bladder cancer (individual patient data)

Surgery (4)

Alvimopan for recovery of bowel function after radical cystectomy

Extended versus standard lymph node dissection for urothelial carcinoma of the bladder in patients undergoing radical cystectomy

Surgery versus radiotherapy for muscle invasive bladder cancer

Robotic versus open radical cystectomy for bladder cancer in adults

Radiotherapy (2)

Neo-adjuvant chemotherapy for invasive bladder cancer

Surgery versus radiotherapy for muscle invasive bladder cancer

Treatment of Metastatic Bladder Cancer (3)

Chemotherapy (To include combination programs) (2)

Cisplatin (0)

Carboplatin (0)

Gemcitabine (1)

Gemcitabine for unresectable, locally advanced or metastatic bladder cancer

Pembrolizumab monotherapy versus chemotherapy for treatment of advanced urothelial carcinoma with disease progression during or following platinum-containing chemotherapy. A Cochrane Rapid Review

Immunotherapy for advanced or metastatic urothelial carcinoma (protocol stage)

Upper tract urothelial carcinoma (1)

Perioperative systemic chemo-immunotherapy for upper urinary tract urothelial carcinoma (protocol stage)

Renal Cancer (Malignancy, Neoplasia): Renal pelvis and ureteral tumors, renal cell carcinoma (7)

Treatment of Renal Pelvis and Ureteral Tumors (0)

Surgery (0)

Nephrourecterectomy (0)

Adjuvant Therapy (0)

Radiation Therapy (0)

Chemotherapy (0)

Cisplatin (0)

Treatment of Renal Cell Carcinoma (7)

Miscellaneous (2)

First-line therapy for adults with advanced renal cell carcinoma: a systematic review and network meta-analysis (protocol stage)

Image-guided percutaneous renal core biopsy of small renal masses to diagnose renal cancer (protocol stage)

Surgery (2)

Cytoreductive nephrectomy in metastatic renal cell carcinoma (protocol stage)

Partial nephrectomy versus radical nephrectomy for clinical localised renal masses

Radiation Therapy (0)

Floxuridine (FUDR) (0)

Immunotherapy (3)

Active-specific (0)

Ethylchlorformate (0)

Dimethyldioctadecylammonium bromide (DDA) (0)

Active-nonspecific (2)

Targeted therapy for advanced renal cell carcinoma

Targeted therapy for metastatic renal cell carcinoma

Bacillus Calmette Guérin (BCG) (0)

Corynebacterium parvum (0)

Interferons (0)

Interleukin-2 (1)

Immunotherapy for metastatic renal cell carcinoma

Other Urologic Cancers (Testicular, Penile, Urethral) (3)

Penile Cancer (Malignancy, Neoplasia) (0)

Treatment of Penile Cancer (0)

Surgery (0)

Active Surveillance (0)

Radiotherapy (including adjuvant) (0)

Nd:YAG Laser (0)

Urethral Cancer (Malignancy, Neoplasia) (2)

Treatment of Urethral Cancer (2)

Surgery (Urinary diversion) (1)

Surgical management for upper urinary tract transitional cell carcinoma

Laser Ablation (0)

Radiation Therapy (0)

Chemotherapy (1)

Single-dose intravesical chemotherapy after nephroureterectomy for upper tract urothelial carcinoma

Cochrane
Urology

Our reviews

Our Reviews

Full list:

By subtopic:

New and Updated (in the latest issue of the CLib):